Literature DB >> 24894709

Sialoendoscopy: a viable treatment for I(131) induced sialoadenitis.

R De Luca1, A Vicidomini2, M Trodella2, G Tartaro2, G Colella2.   

Abstract

To evaluate the viability, efficacy, and safety of sialoendoscopy for the diagnosis and management of radioiodine I(131-) related sialoadenitis, we retrospectively reviewed 30 patients referred between September 2007 and July 2013 from the Thyroid Surgery Unit to the Maxillofacial Unit of the Second University of Naples Hospital with persistent sialoadenitis after treatment with I(131). After the affected gland had been isolated, the endoscope was introduced into the duct under local anaesthesia with 2% lignocaine and continuous lavage with isotonic saline, and was advanced until it reached the ductal system. We studied 24 women and 6 men, mean (SD) age 52 (??) years. In 25 patients I(131) was given for papillary (83%), in 3 for medullary (10%), and in 2 for follicular thyroid carcinoma (7%). Stenosis alone was found in 30 glands (40%), mucous plugs alone in 35 (47%), and mucous plugs, stenosis, and kinks in 10 (13%). Of the 75 glands, dilatation of the ducts was successful in 70, and we completely removed all mucous plugs and kinks. We achieved symptomatic improvement in 23 patients (77%) during a follow-up ranging from 2 weeks to 84 months. Sialoendoscopy is a viable technique for the diagnosis of obstructive salivary disease, and is a safe and effective way to treat sialoadenitis, the most common complication of treatment with I(131).
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  I 131 induced sialoadenitis; Imaging in salivary diseases; Sialoendoscopy

Mesh:

Substances:

Year:  2014        PMID: 24894709     DOI: 10.1016/j.bjoms.2014.01.025

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  8 in total

Review 1.  Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.

Authors:  E N Klein Hesselink; T P Links
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT.

Authors:  Hendrik Rathke; Clemens Kratochwil; Ralph Hohenberger; Frederik Lars Giesel; Frank Bruchertseifer; Paul Flechsig; Alfred Morgenstern; Matti Hein; Peter Plinkert; Uwe Haberkorn; Olcay Cem Bulut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-27       Impact factor: 9.236

3.  [Inflammation grading and sialoendoscopic treatment of 131I radioiodine-induced sialadenitis].

Authors:  X Li; J Z Su; Y Y Zhang; L Q Zhang; Y Q Zhang; D G Liu; G Y Yu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-06-18

4.  Quality of life after sialendoscopy: prospective non-randomized study.

Authors:  Giulianno Molina Melo; Murilo Catafesta Neves; Marcello Rosano; Christiana Maria Ribeiro Salles Vanni; Marcio Abrahao; Onivaldo Cervantes
Journal:  BMC Surg       Date:  2022-01-08       Impact factor: 2.102

5.  Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching.

Authors:  Ye Liu; Yuhua Wang; Wanchun Zhang
Journal:  Front Surg       Date:  2022-09-22

Review 6.  Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?

Authors:  Marios Adramerinas; Dimitrios Andreadis; Konstantinos Vahtsevanos; Athanasios Poulopoulos; Kalliopi Pazaitou-Panayiotou
Journal:  Hormones (Athens)       Date:  2021-06-18       Impact factor: 2.885

Review 7.  Interventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?

Authors:  P Canzi; S Cacciola; P Capaccio; F Pagella; A Occhini; L Pignataro; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

8.  Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy.

Authors:  Euy-Hyun Kim; Dong-Keon Lee; Chang-Woo Kim; In-Seok Song; Sang-Ho Jun
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.